Penumbra wins CE mark for Thunderbolt clot removal tech

Penumbra wins CE mark for Thunderbolt clot removal tech is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-06-18

The international launch could benefit from Boston Scientific’s global footprint when the company closes its takeover of Penumbra.

Source: MedTech Dive